Noninvasive and minimally invasive detection and monitoring of peripheral neuropathies

Expert Review of Neurotherapeutics

Volumn 8, Issue 12, 2008, Pages 1807-1816

  Herrmann, David N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Clinical trial; Corneal confocal microscopy; Diagnosis; Epidermal nerve fiber density; Evoked potential; In vivo reflectance confocal microscopy; Meissner corpuscle; Nerve conduction study; Noninvasive; Outcome measure; Peripheral neuropathy

Indexed keywords

ANAMNESIS; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFOCAL MICROSCOPY; DISEASE COURSE; EVOKED RESPONSE; HISTOPATHOLOGY; HUMAN; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; NERVE POTENTIAL; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; REVIEW; SCORING SYSTEM; SCREENING TEST; SENSORY NERVE; SENSORY NEUROPATHY; SENSORY SYSTEM EXAMINATION; SKIN BIOPSY; SKIN NERVE; THERMAL CONDUCTIVITY;

BIOPSY; ELECTROPHYSIOLOGY; EVOKED POTENTIALS, SOMATOSENSORY; HUMANS; MICROSCOPY, CONFOCAL; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM DISEASES; SKIN;

EID: 57749207732     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.8.12.1807     Document Type: Review

References (86)

1. Boulton AJ. Whither clinical research in diabetic sensorimotor peripheral neuropathy? Problems of end point selection for clinical trials. Diabetes Care 30(10), 2752-2753 (2007).
2. Herrmann DN, Bromberg MB. Chili peppers, nerve regeneration and clinical trial design. Neurology 68(16), 1247-1248 (2007).
3. England JD, Gronseth GS, Franklin G et al. Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64(2), 199-207 (2005).
4. Apfel SC, Asbury AK, Bril V et al. Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials: ad hoc panel on endpoints for diabetic neuropathy trials. J. Neurol. Sci. 189(1-2), 3-5 (2001).
5. Dworkin RH, Turk DC, Farrar JT et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1-2), 9-19 (2005).
6. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the neuropathic pain scale. Neurology 48(2), 332-338 (1997).
7. Bastyr EJ 3rd, Price KL, Bril V; the MBBQ Study Group. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin. Ther. 27(8), 1278-1294 (2005).
8. Grant IA, O'Brien P, Dyck PJ. Neuropathic assessment. In: Diabetic Neuropathy (2nd Edition). Dyck PJ, Thomas Pk (Eds.). WB Saunders Company, PA, USA (1999).
9. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Klein CJ, Dyck PJ. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care 28(9), 2192-2200 (2005).
10. Dyck PJ, Norell JE, Tritschler H et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care 30(10), 2619-2625 (2007).
11. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49(1), 229-239 (1997).
12. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17(11), 1281-1289 (1994).
13. Bril V, Perkins BA. Validation of the Toronto clinical scoring system for diabetic polyneuropathy. Diabetes Care 25(11), 2048-2052 (2002).
14. Position statement: standards of medical care in diabetes American Diabetes Association. Diabetes Care 27(S1), 15-35 (2004).
15. Cornblath DR, Chaudhry V, Carter K et al. Total neuropathy score: validation and reliability study. Neurology 53(8), 1660-1664 (1999).
16. Shy ME, Chen L, Swan ER et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 70(5), 378-383 (2008).
17. Shy ME, Blake J, Krajewski K et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64(7), 1209-1214 (2005).
18. Tesfaye S, Tandan R, Bastyr EJ 3rd et al. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care 30(10), 2626-2632 (2007).
19. Bird SJ, Brown MJ, Spino C, Watling S, Foyt HL. Value of repeated measures of nerve conduction and quantitative sensory testing in a diabetic neuropathy trial. Muscle Nerve 34(2), 214-224 (2006).
20. Rappaport BA. Current FDA Policy on analgesic drug and biologic product development. Presented at: 10th International Conference on the Mechanisms and Treatment of Neuropathic Pain. Snowbird, UT, USA, 2 November, 2007.
21. Quattrini C, Tavakoli M, Jeziorska M et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56(8), 2148-2154 (2007).
22. Herrmann DN, Ferguson ML, Pannoni V et al. The plantar nerve AP and skin biopsy in sensory neuropathies with normal routine conduction studies. Neurology 63(5), 879-885 (2004).
23. Herrmann DN, Griffin JW, Hauer P, Cornblath DR, McArthur JC. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 53(8), 1634-1640 (1999).
24. Suarez GA, Dyck PJ. Quantitative sensory assessment. In: Diabetic Neuropathy (2nd Edition). Dyck PJ, Thomas PK (Eds). WB Saunders Company, PA, USA (1999).
25. Gruener G, Dyck PJ. Quantitative sensory testing: methodology, applications, and future directions. J. Clin. Neurophysiol. 11(6), 568-583 (1994).
26. Dyck PJ, Dyck PJ, Kennedy WR et al. Limitations of quantitative sensory testing when patients are biased toward a bad outcome. Neurology 50(5), 1213 (1998).
27. Dyck PJ, O'Brien PC. Quantitative sensation testing in small-diameter sensory fiber neuropathy. Muscle Nerve 26(5), 595-596 (2002).
28. Shy ME, Frohman EM, So YT et al. Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 60(6), 898-904 (2003).
29. Chong PS, Cros DP. Technology literature review: quantitative sensory testing. Muscle Nerve 29(5), 734-747 (2004).
30. Periquet MI, Novak V, Collins MP et al. Painful sensory neuropathy: prospective evaluation using skin biopsy. Neurology 53(8), 1641-1647 (1999).
31. Berger AR, Arezzo JC, Schaumburg HH et al. 2′,3′- dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology 43(2), 358-362 (1993).
32. Brown MJ, Bird SJ, Watling S et al. Natural progression of diabetic peripheral neuropathy in the Zenarestat study population. Zenarest study. Diabetes Care 27(5), 1153-1159 (2004).
33. Herrmann DN, McDermott MP, Henderson D et al. Epidermal nerve fiber density, axonal swellings and QST as predictors of HIV distal sensory neuropathy. Muscle Nerve. 29(3), 420-427 (2004).
34. Simpson DM, Kitch D, Evans SR et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 66(11), 1679-1687 (2006).
35. Herrmann DN, McDermott MP, Sowden JE et al. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study. Neurology 66(6), 857-861 (2006).
36. Chaudhry V, Eisenberger MA, Sinibaldi VJ, Sheikh K, Griffin JW, Cornblath DR. A prospective study of suramin-induced peripheral neuropathy. Brain 119(6), 2039-2052 (1996).
37. Chaudhry V, Cornblath DR, Corse A, Freimer M, Simmons-O'Brien E, Vogelsang G. Thalidomide-induced neuropathy. Neurology 59(12), 1872-1875 (2002).
38. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann. Neurol. 35(3), 304-311 (1994).
39. Apfel SC, Schwartz S, Adornato BT et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA 284(17), 2215-2221 (2000).
40. Schifitto G, Yiannoutsos C, Simpson DM et al. Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy. Neurology 57(7), 1313-1316 (2001).
41. Hilz MJ, Brys M, Marthol H, Stemper B, Dutsch M. Enzyme replacement therapy improves function of C-, Aδ- and Aβ-nerve fibers in Fabry neuropathy. Neurology 62(7), 1066-1072 (2004).
42. Mayfield JA, Sugarman JR. The use of the Semmes-Weinstein monofilament and other threshold tests for preventing foot ulceration and amputation in persons with diabetes. J. Fam. Pract. 49(11 Suppl.), S17-S29 (2000).
43. Coppini DV, Young PJ, Weng C, Macleod AF, Sönksen PH. Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet. Med. 15(9), 765-771 (1998).
44. Rolke R, Baron R, Maier C et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123(3), 231-243 (2006).
45. Treede RD, Lorenz J, Baumgärtner U. Clinical usefulness of laser-evoked potentials. Neurophysiol. Clin. 33(6), 303-314 (2003).
46. Pozzessere G, Rossi P, Gabriele A et al. Early detection of small-fiber neuropathy in diabetes: a laser-induced pain somatosensory-evoked potentials and pupillometric study. Diabetes Care 25(12), 2355-2358 (2002).
47. Atherton DD, Facer P, Roberts KM et al. Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fiber neuropathy: correlations with skin flare responses and intra-epidermal nerve fiber counts. BMC Neurol. 7, 21 (2007).
48. Chao CC, Hsieh SC, Tseng MT, Chang YC, Hsieh ST. Patterns of contact heat evoked potentials (CHEP) in neuropathy with skin denervation: correlation of CHEP amplitude with intra-epidermal nerve fiber density. Clin. Neurophysiol. 119(3), 653-661 (2008).
49. Obermann M, Katsarava Z, Esser S et al. Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy. Pain 138(1), 79-86 (2008).
50. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch. Neurol. 55(12), 1513-1520 (1998).
51. Kennedy WR, Wendelschafer-Crabb G, Johnson T. Quantitation of epidermal nerves in diabetic neuropathy. Neurology 47(4), 1042-1048 (1996).
52. Smith AG, Howard JR, Kroll R et al. The reliability of skin biopsy with measurement of intraepidermal nerve fiber density. J. Neurol. Sci. 228(1), 65-69 (2005).
53. Koskinen M, Hietaharju A, Kyläniemi M et al. A quantitative method for the assessment of intraepidermal nerve fibers in small-fiber neuropathy. J. Neurol. 252(7), 789-794 (2005).
54. Devigili G, Tugnoli V, Penza P et al. The diagnostic criteria for small fiber neuropathy: from symptoms to neuropathology. Brain 131(7), 1912-1925 (2008).
55. Lauria G, Cornblath DR, Johansson O et al. European Federation of Neurological Societies. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol. 12(10),747-758 (2005).
56. Polydefkis M, Yiannoutsos CT, Cohen BA et al. Reduced intra-epidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58(1), 115-119 (2002).
57. Shun CT, Chang YC, Wu HP et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 127(7), 1593-1605 (2004).
58. Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology 65(6), 925-927 (2005).
59. McCarthy BG, Hsieh ST, Stocks A et al. Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology 45(10), 1848-1855 (1995).
60. Holland NR, Crawford TO, Hauer P et al. Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann. Neurol. 44(1), 47-59 (1998).
61. Løseth S, Lindal S, Stålberg E, Mellgren SI. Intraepidermal nerve fiber density, quantitative sensory testing and nerve conduction studies in a patient material with symptoms and signs of sensory polyneuropathy. Eur. J. Neurol. 13(2), 105-111 (2006).
62. Schiffmann R, Hauer P, Freeman B et al. Enzyme replacement therapy and intraepidermal innervation density in Fabry disease. Muscle Nerve 34(1), 53-56 (2006).
63. Lauria G, Morbin M, Lombardi R et al. Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61(5), 631-636 (2003).
64. Vlcková-Moravcová E, Bednarík J, Dusek L, Toyka KV, Sommer C. Diagnostic validity of epidermal nerve fiber densities in painful sensory neuropathies. Muscle Nerve 37(1), 50-60 (2008).
65. Ebenezer GJ, McArthur JC, Thomas D et al. Denervation of skin in neuropathies: the sequence of axonal and Schwann cell changes in skin biopsies. Brain 130(10), 2703-2714 (2007).
66. Li J, Bai Y, Ghandour K et al. Skin biopsies in myelin-related neuropathies: bringing molecular pathology to the bedside. Brain 128(5), 1168-1177 (2005).
67. Sabet A, Li J, Ghandour K et al. Skin biopsies demonstrate MPZ splicing abnormalities in Charcot-Marie-Tooth neuropathy 1B. Neurology 67(7), 1141-1146 (2006).
68. Lombardi R, Erne B, Lauria G et al. IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy. Ann. Neurol. 57(2), 163-167 (2005).
69. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127(7), 1606-1615 (2004).
70. Hahn K, Sirdofsky M, Brown A et al. Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy. J. Peripher. Nerv. Syst. 11(2), 142-147 (2006).
71. Polydefkis M, Sirdofsky M, Hauer P et al. Factors influencing nerve regeneration in a trial of timcodar dimesylate. Neurology 66(2), 259-261 (2006).
72. Hahn K, Triolo A, Hauer P et al. Impaired reinnervation in HIV infection following experimental denervation. Neurology 68(16), 1251-1256 (2007).
73. Hossain P, Sachdev A, Malik RA et al. Early detection of diabetic peripheral neuropathy with corneal confocal microscopy. Lancet 366(9494), 1340-1343 (2005).
74. Mehra S, Tavakoli M, Kallinikos PA et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with Type 1 diabetes. Diabetes Care 30(10), 2608-2612 (2007).
75. Rajadhyaksha M, Gonzalez S, Zavislan JM, Anderson RR, Webb RH. In vivo confocal scanning laser microscopy of human skin II: advances in instrumentation and comparison with histology. J. Invest. Dermatol. 113(3), 293-303 (1999).
76. Busam K, Hester K, Charles C et al. Detection of clinically amelanotic malignant melanoma and assessment of its margins by in vivo confocal scanning laser microscopy (CSLM). Arch. Dermatol. 137(7), 923-929 (2001).
77. Langley R, Rajadhyaksha M, Dwyer P, Sober A, Flotte T, Anderson RR. Confocal scanning laser microscopy of benign and malignant melanocytic skin lesions in vivo. J. Am. Acad. Dermatol. 45(3), 365-376 (2001).
78. Bolton C, Winkelmann R, Dyck P. A quantitative study of Meissner's corpuscles in man. Neurology 16(1), 1-9 (1966).
79. Pare M, Elde R, Mazurkiewicz JE, Smith AM, Rice FL. The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties. J. Neurosci. 21(18), 7236-7246 (2001).
80. Nolano M, Provitera V, Crisci C et al. Quantification of myelinated endings and mechanoreceptors in human digital skin. Ann. Neurol. 54(2) 197-205 (2003).
81. Nolano M, Provitera V, Lullo F et al. Meissner corpuscles and myelinated nerve fibers in human digital skin: a correlation with electrophysiological findings. J. Peripher. Nerv. Syst. 6(3), 165 (2001).
82. Nolano M, Provitera V, Lullo F et al. Tactile stimulation and mechanoreceptors in sensory neuropathies. Neurol. Sci. 22(1), S31-S36 (2001).
83. Jabaley ME, Burns JE, Orcutt BS, Bryant M. Comparison of histologic and functional recovery after peripheral nerve repair. J. Hand Surg. [Am.] 1(2), 119-130 (1976).
84. Hsieh ST, Chu NS. Immunohistochemical study of skin nerve regeneration after toe-to-finger transplantation: correlations with clinical, quantitative sensory, and electrophysiological evaluations. Acta Neurol. Taiwan 13(4), 178-185 (2004).
85. Herrmann DN, Boger NJ, Jansen C, Alessi-Fox C. In vivo confocal microscopy of Meissner's corpuscles as a measure of sensory neuropathy. Neurology 69(23), 2121-2127 (2007).
86. Peripheral Neuropathy Course syllabus. American Academy of Neurology Annual Meeting. San Diego, CA, USA, 1-8 April 2006 (7FC.002-91).